Browse studies

Find your next paid study

29 recruiting studies matching your filters

Randomized Controlled Trial of Computerized Decision Support for Prevention of Venous Thromboembolism in Hospitalized Medical Patients Across the Continuum of Care (DC-eALERT)

Hospitalized medical patients have an increased risk of venous thromboembolism (VTE) across the continuum of care, including after hospital discharge. In the A…

Venous Thromboembolism

Estimated

~$10 – $6,250

Brigham and Women's HospitalNCT03728166

Phase 3

A 2-Part, Phase 3, Multicenter, Randomized, Open-Label, Active-Controlled Study to Assess Efficacy and Safety of REGN7508, a Monoclonal Antibody Against Factor XI, for the Treatment and Secondary Prevention of Venous Thromboembolism in Participants With Solid and Hematologic Cancers (ROXI-CAT-II)

This study is researching an experimental drug called REGN7508 (called "study drug") and will consist of 2 parts: Part 1 and Part 2. The study is focused on pa…

Venous Thromboembolism (VTE)

Estimated

~$10 – $8,750

Regeneron PharmaceuticalsNCT07493304

Phase 3

A Phase 3, Multicenter, Randomized, Open-Label, Study to Evaluate REGN7508, A Factor XI Monoclonal Antibody, Versus Apixaban and Enoxaparin for Prophylaxis of Venous Thromboembolism After Elective Total Knee Arthroplasty (ROXI-APEX)

This study is researching an experimental drug called REGN7508 (called "study drug"). The study is focused on adults undergoing elective, unilateral (one side)…

Venous Thromboembolism (VTE)

Estimated

~$10 – $8,750

Regeneron PharmaceuticalsNCT07015905

Phase 3

A Phase 3, Multicenter, Double-Blinded, Randomized Study to Evaluate REGN7508, a Factor XI Monoclonal Antibody, Versus Acetylsalicylic Acid for Prophylaxis of Symptomatic Venous Thromboembolism After Elective Total Knee Arthroplasty (ROXI-ASPEN)

This study is researching an experimental drug called REGN7508 (called "study drug") and how it compares against another treatment called Acetylsalicylic Acid …

Symptomatic Venous Thromboembolism (VTE)

Estimated

~$10 – $8,750

Regeneron PharmaceuticalsNCT07213778

Long-Term CLinical Evaluation of Aspiration ThRombectomy Using the Symphony or ProdIgy Thrombectomy System - CLEAR-IT

The study is designed to evaluate the short-term and long-term clinical performance and safety of the Symphony and Prodigy thrombectomy systems used in endovas…

Arterial ThromboembolismVenous ThromboembolismPulmonary Embolism

Estimated

~$10 – $1,050

Imperative Care, Inc.NCT07350499

Computerized Registry of Patients With Venous Thromboembolism (RIETE)

The Computerized Registry of Patients with Venous Thromboembolism (RIETE) is a multidisciplinary Project initiated in march 2001 and consisting in obtaining an…

Venous Thromboembolism

Estimated

~$10 – $1,125

Manuel MonrealNCT02832245

Phase 4

STAT-CAT: Statin Therapy to Prevent Cancer Associated Venous Thromboembolism

Patients with cancer are at high risk for life-threatening venous thromboembolism (VTE) yet rarely receive anticoagulant prophylaxis due to bleeding risks. Thu…

Venous ThromboembolismCancerCardiovascular Events

Estimated

~$10 – $6,250

Brigham and Women's HospitalNCT07303816

Observational

The PERSEVERE Study

Randomized Controlled Trial of High-Risk Pulmonary Embolism Comparing FlowTriever System vs. Standard of Care

Pulmonary EmbolismPulmonary Thromboembolism

Estimated

~$10 – $7,500

Inari MedicalNCT06588634

Observational

DEFIANCE - ClotTriever® Thrombectomy System vs. Anticoagulation Alone for Treatment of Deep Vein Thrombosis

This study is a prospective, multicenter, randomized controlled trial of an interventional strategy using the ClotTriever System to achieve and maintain vessel…

Venous ThromboembolismDeep Venous ThrombosisPost-Thrombotic Syndrome

Estimated

~$10 – $7,500

Inari MedicalNCT05701917

Phase 4

Extended Prophylactic Anticoagulation Following Spinal Surgery for Metastatic Disease

People who have surgery on their spine to treat cancer that has spread (metastatic disease) have a high chance of developing dangerous blood clots in the legs …

Venous Thromboembolism (VTE)Deep Vein Thrombosis (DVT)Pulmonary Embolism (PE)+1 more

Estimated

~$10 – $7,500

James BayleyNCT07713875

Phase 2

Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Major Colorectal Surgery

The goal of this prospective pragmatic randomized clinical trial is to determine if preoperative administration of tranexamic acid (TXA) reduces bleeding durin…

BleedingColorectal DisordersThromboembolism+1 more

Estimated

~$10 – $7,500

Kristen BanNCT06657924

Measurement of Adherence and Health-related Quality of Life, and Health-Care Resource Utilization During Anticoagulation Therapy in Cancer-Related Venous Thromboembolism (VTE)

The goal of this research study is to learn about the quality of life, experiences with treatment, and healthcare costs of patients who are receiving long-term…

Cancer-related Venous Thromboembolism

Estimated

~$10 – $750

M.D. Anderson Cancer CenterNCT03407469